Xeris Pharmaceuticals | XERS - Interest Income


Xeris Pharmaceuticals reported $1.16M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Celltrion KRW 621.35M 55.31M Dec/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 2.3M 6.24M Dec/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Sartorius EUR -31.8M 86.7M Dec/2025
Supernus Pharmaceuticals USD 2.02M 254K Dec/2025
Tilray USD 12.83M 20.19M May/2024
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026